Clinical Trial Update: Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing norethindrone acetate to leuprolide acetate (Lupron) for treatment of endometriosis and related dysmenorrhea and dyspareunia; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Dyspareunia
• Endometriosis

Drugs mentioned

• LUPRON DEPOT (LEUPROLIDE ACETATE)
• Norethindrone acetate (Norethindrone acetate)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Endometriosis, Dysmenorrhea | Phase 3 | Status: UNKNOWN